Avista Healthcare
BRIDGEWATER, N.J., Aug. 04, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1%, today announced that it has entered into arrangements to secure up to $68.9 million in committed financing through a combination of equity and non-dilutive […]
With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry BLUE BELL, Pa., July 28, 2022 /PRNewswire/ — UBC, a biopharmaceutical leader providing integrated clinical, safety, and commercialization services, today announced that it has acquired Examoto, LLC, a Risk Evaluation and Mitigation Strategy (REMS) company. Examoto is dedicated […]
First Ever Phase 3 Program to Show Improvement in Both Symptoms and Inflammation Inside the Sinuses with a Nasal Therapy for Chronic Sinusitis Patients Physicians Diagnose Chronic Sinusitis 10 Times More Frequently Than XHANCE’s Current Nasal Polyps Indication and there is no FDA-Approved Medication for these Patients Conference call and webcast to be held today at 8:30 a.m. […]
NEW YORK, April 27, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has closed on the sale of Inform Diagnostics (“Inform Diagnostics”) to Fulgent Genetics (NASDAQ: FLGT). Inform Diagnostics is one of the largest national pathology laboratories in the United States with offerings across gastrointestinal […]
Proposed acquisition will add diagnostic offerings, including hematopathology and anatomic pathology, while also providing a highly complementary nationwide commercial infrastructure to support Fulgent’s rapidly expanding genomic testing footprint Preliminary first quarter revenue results expected to exceed previous guidance provided on February 23, 2022 Fulgent updates full year 2022 core revenue guidance to approximately $175 million […]
— Combined Organizations Plan to Expand Adoption of Innovative Dental Treatment Isolation Technology — NORTHBOROUGH, Mass. and FOUNTAIN VALLEY, Calif., April 11, 2022 /PRNewswire/ — Solmetex, LLC, the dental industry’s leading provider of amalgam separators and other waste compliance products, today announced that it has closed the acquisition of DryShield®, a dental innovator of in-treatment patient isolation products, combining […]
— Combined Company Poised to Transform the Dental Water Treatment Category, Drive Innovation, and Improve Safety — NORTHBOROUGH, Mass. and PALMER LAKE, Colo., April 5, 2022 /PRNewswire/ — Solmetex, LLC, the dental industry’s leading provider of amalgam separators and other waste compliance products, today announced that it has signed an agreement to acquire Sterisil®, a leading innovator of dental […]
TAMPA, Fla., April 4, 2022 /PRNewswire/ — Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, today announced the completion of its acquisition of Canute Medical (“Canute”). Terms of the transaction were not disclosed. Canute, incorporated in 2012, is a leading service provider for installation, de-installation, removals, and remarketing of pre-owned medical […]
Transaction will result in OmniAb becoming an independent publicly-traded company Ligand’s shareholders to receive 100% of Ligand’s shares in OmniAb through a tax-free distribution immediately prior to the merger EMERYVILLE, Calif. & NEW YORK — March 23, 2022 — (BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (Ligand) (NASDAQ: LGND) today announced the signing of a definitive merger […]
NEW YORK, NY – March 10, 2022 – Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that Neil Ferguson has joined the firm as a Strategic Executive. Mr. Ferguson is a proven executive who joins Avista after 35 years in the healthcare and pharmaceutical industries, with the majority […]
BLUE BELL, Pa., March 9, 2022 /PRNewswire/ — UBC announced today that it has acquired MarketShare Movers (“MSM”), a data-driven prescription drug benefit and affordability company. As prescription drug affordability continues to be a leading driver of prescription abandonment and dosing reductions in healthcare today, developing strategies surrounding patient affordability programs will continue to be front and […]
XHANCE met both co-primary endpoints in the ReOpen1 trial, demonstrating statistically significant benefits on symptoms and CT scans in patients with chronic sinusitis There are no FDA-approved drug treatments for the 30 million adults in the U.S. with chronic sinusitis Conference call and webcast to be held today at 4:15 p.m. Eastern Time YARDLEY, Pa., March 07, 2022 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), […]